Live guideline-concordance dashboards for every tumour board, generated from the record
Hospitals rarely know what fraction of their patients got the recommended treatment. Software reading the electronic record can show each team, every month, where care deviated from guidelines.
Guideline adherence varies widely between hospitals and is usually measured years later by registry studies. Structured oncology data (mCODE-style) and rule engines encoding guideline pathways make near-real-time concordance measurement possible. Each multidisciplinary team would see its own concordance by tumour type and stage, with justified deviations flagged separately from unjustified ones, and could compare against peers.
- Fragmented care and guideline gaps · Patients fall between specialists, wait for referrals and often do not get the treatment guidelines say they should.
- Knowledge reaches practice too slowly · Knowledge diffusion is slow: it takes years for a proven result to change what most patients receive, and no one can keep up with the literature.
- Data silos · Records, scans, genomes and outcomes sit in separate systems that cannot talk. Every patient's experience is lost to the next.
Pages like this
not linked directly; found by shared links- IdeaA guideline fast track for repurposed drugs with phase 3 evidence but no manufacturer
Shares ESMO Clinical Practice Guidelines & MCBS, NCCN Guidelines, Knowledge reaches practice too slowly.
- IdeaGuidelines list the open trials at every decision point, updated monthly
Shares ESMO Clinical Practice Guidelines & MCBS, NCCN Guidelines, Knowledge reaches practice too slowly.
- IdeaLabel every biomarker claim with an evidence phase, like drugs
Shares ESMO Clinical Practice Guidelines & MCBS, NCCN Guidelines, Knowledge reaches practice too slowly.
- IdeaOpen licences for publicly funded cancer guidelines
Shares NCCN Guidelines, Knowledge reaches practice too slowly.
- IdeaOffline decision support for generalists treating common cancers in low-resource settings
Shares NCCN Guidelines, Knowledge reaches practice too slowly.
- IdeaAn asynchronous expert second opinion for every new advanced-cancer diagnosis
Shares Fragmented care and guideline gaps, Knowledge reaches practice too slowly.
- IdeaA fixed share of trial-group funding for getting proven care to patients
Shares ESMO Clinical Practice Guidelines & MCBS, NCCN Guidelines, Fragmented care and guideline gaps.
- IdeaAlert guidelines and trials when a paper they rely on is retracted
Shares ESMO Clinical Practice Guidelines & MCBS, NCCN Guidelines.